Gw&K Investment Management, LLC Arcutis Biotherapeutics, Inc. Transaction History
Gw&K Investment Management, LLC
- $11.7 Billion
- Q3 2024
A detailed history of Gw&K Investment Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,593,630 shares of ARQT stock, worth $22.1 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,593,630
Previous 1,667,979
4.46%
Holding current value
$22.1 Million
Previous $15.5 Million
4.46%
% of portfolio
0.13%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
130MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC12.3MShares$171 Million0.11% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$152 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$148 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$122 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$119 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $834M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...